Logo image of HTA

HEALTHCARE TRUST OF AME-CL A (HTA) Stock Fundamental Analysis

NYSE:HTA - US42225P5017 - REIT

29.19 USD
-0.02 (-0.07%)
Last: 7/20/2022, 8:04:00 PM
29.23 USD
+0.04 (+0.14%)
After Hours: 7/20/2022, 8:04:00 PM
Fundamental Rating

1

HTA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. HTA has a bad profitability rating. Also its financial health evaluation is rather negative. HTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HTA was profitable.
HTA Yearly Net Income VS EBIT VS OCF VS FCFHTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -500M -1B -1.5B -2B

1.2 Ratios

Industry RankSector Rank
ROA 1.38%
ROE 2.94%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HTA Yearly ROA, ROE, ROICHTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6

1.3 Margins

Industry RankSector Rank
OM 23.13%
PM (TTM) 12.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HTA Yearly Profit, Operating, Gross MarginsHTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

HTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HTA has more shares outstanding
The debt/assets ratio for HTA has been reduced compared to a year ago.
HTA Yearly Shares OutstandingHTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
HTA Yearly Total Debt VS Total AssetsHTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

A Debt/Equity ratio of 0.95 indicates that HTA is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.43%
HTA Yearly LT Debt VS Equity VS FCFHTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B -2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.54% over the past year.
Measured over the past 5 years, HTA shows a small growth in Earnings Per Share. The EPS has been growing by 6.58% on average per year.
The Revenue has been growing slightly by 4.43% in the past year.
Measured over the past years, HTA shows a quite strong growth in Revenue. The Revenue has been growing by 10.72% on average per year.
EPS 1Y (TTM)61.54%
EPS 3Y25.99%
EPS 5Y6.58%
EPS Q2Q%-20%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y3.27%
Revenue growth 5Y10.72%
Sales Q2Q%5.48%

3.2 Future

Based on estimates for the next years, HTA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.57% on average per year.
The Revenue is expected to grow by 4.05% on average over the next years.
EPS Next Y-3.59%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
EPS Next 5Y9.57%
Revenue Next Year6.57%
Revenue Next 2Y4.52%
Revenue Next 3Y4.63%
Revenue Next 5Y4.05%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HTA Yearly Revenue VS EstimatesHTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
HTA Yearly EPS VS EstimatesHTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 69.50 indicates a quite expensive valuation of HTA.
The average S&P500 Price/Earnings ratio is at 27.08. HTA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 62.38 indicates a quite expensive valuation of HTA.
The average S&P500 Price/Forward Earnings ratio is at 22.72. HTA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 69.5
Fwd PE 62.38
HTA Price Earnings VS Forward Price EarningsHTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.04
HTA Per share dataHTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)10.57
EPS Next 2Y3.13%
EPS Next 3Y7.42%

More info and screens

1

5. Dividend

5.1 Amount

HTA has a yearly dividend return of 0.40%, which is pretty low.
With a Dividend Yield of 0.40, HTA pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.4%

5.2 History

HTA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
HTA Yearly Dividends per shareHTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8 1

5.3 Sustainability

HTA pays out 303.50% of its income as dividend. This is not a sustainable payout ratio.
DP303.5%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
HTA Yearly Income VS Free CF VS DividendHTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 -500M -1B -1.5B -2B
HTA Dividend Payout.HTA Dividend Payout, showing the Payout Ratio.HTA Dividend Payout.PayoutRetained Earnings

More info and screens

HEALTHCARE TRUST OF AME-CL A

NYSE:HTA (7/20/2022, 8:04:00 PM)

After market: 29.23 +0.04 (+0.14%)

29.19

-0.02 (-0.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-05 2022-05-05/amc
Earnings (Next)08-05 2022-08-05/amc
Inst Owners0.01%
Inst Owner Change0%
Ins Owners0.62%
Ins Owner Change0%
Market Cap6.69B
Analysts71.43
Price Target33.72 (15.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.4%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP303.5%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 69.5
Fwd PE 62.38
P/S 8.6
P/FCF N/A
P/OCF N/A
P/B 2.08
P/tB N/A
EV/EBITDA 21.04
EPS(TTM)0.42
EY1.44%
EPS(NY)0.47
Fwd EY1.6%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.39
BVpS14.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)10.57
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 23.13%
PM (TTM) 12.13%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.54%
EPS 3Y25.99%
EPS 5Y6.58%
EPS Q2Q%-20%
EPS Next Y-3.59%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
EPS Next 5Y9.57%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y3.27%
Revenue growth 5Y10.72%
Sales Q2Q%5.48%
Revenue Next Year6.57%
Revenue Next 2Y4.52%
Revenue Next 3Y4.63%
Revenue Next 5Y4.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A